Stephen L. Huhn serves as Executive at Contineum Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Stephen L. Huhn has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 13, 2024 involved exercising options for 12,800 shares valued at $12.9K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 13, 2024 | CTNM | $12.9K | Option Exercise | 12,800 | $1.01 | Discretionary |
Stephen L. Huhn currently holds 12,800 shares of Contineum Therapeutics, Inc. (CTNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen L. Huhn has been a net neutral trader of CTNM stock. They have purchased $0 and sold $0 worth of shares.
Stephen L. Huhn's most recent insider trade was on Aug 13, 2024, when they sold 12,800 shares at $1.01 per share.
Get notified when new Form 4 filings are submitted